Literature DB >> 21422202

Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.

Federico Perez1, Michael J Pultz, Andrea Endimiani, Robert A Bonomo, Curtis J Donskey.   

Abstract

An understanding of the impact of antibiotics on the intestinal reservoir of KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is important to prevent its emergence. We used a mouse model to examine the effect of antibiotic treatment on the establishment and elimination of intestinal colonization with KPC-Kp. Mice (10 per group) received subcutaneous antibiotics daily for 8 days. On day 3 of treatment, 10(3) CFU of KPC-Kp was given orogastrically, and concentrations of KPC-Kp in stool were monitored. Additional experiments assessed the effects of antibiotic treatment on concentrations of total anaerobes and Bacteroides spp. in stool and the efficacy of orogastric gentamicin and polymyxin E in suppressing KPC-Kp colonization. Of four antibiotics with minimal activity against the KPC-Kp test strain (MIC ≥ 16 μg/ml), those that suppressed total anaerobes and bacteroides (i.e., clindamycin and piperacillin-tazobactam) promoted colonization by KPC-Kp (P < 0.001), whereas agents that did not suppress total anaerobes or bacteroides (i.e., ciprofloxacin and cefepime) did not (P = 0.35). Of two agents with moderate activity against the KPC-Kp test strain, ertapenem (MIC, 4 μg/ml) did not promote colonization by KPC-Kp, whereas tigecycline (MIC, 3 μg/ml) did (P < 0.001), despite not reducing levels of total anaerobes or bacteroides. Orogastric treatment with gentamicin and polymyxin E suppressed KPC-Kp to undetectable levels in the majority of mice. These data suggest that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against KPC-Kp promote colonization by this organism. The administration of nonabsorbed oral antibiotics may be an effective strategy to suppress colonization with KPC-Kp.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422202      PMCID: PMC3101444          DOI: 10.1128/AAC.00891-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients.

Authors:  Yee Gyung Kwak; Sang-Ho Choi; Eun Ju Choo; Jin-Won Chung; Jin-Yong Jeong; Nam Joong Kim; Jun-Hee Woo; Jiso Ryu; Yang Soo Kim
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

Review 3.  Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.

Authors:  Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

4.  Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 5.  Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Authors:  Elizabeth B Hirsch; Vincent H Tam
Journal:  J Antimicrob Chemother       Date:  2010-04-08       Impact factor: 5.790

6.  Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.

Authors:  Mathias W R Pletz; Mareike Rau; Juergen Bulitta; Andres De Roux; Olaf Burkhardt; Guido Kruse; Michael Kurowski; Carl E Nord; Hartmut Lode
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery.

Authors:  B Brismar; C Edlund; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

8.  Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  Claudia K Hoyen; Nicole J Pultz; David L Paterson; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

9.  Effect of piperacillin/tazobactam treatment on human bowel microflora.

Authors:  C E Nord; B Brismar; B Kasholm-Tengve; G Tunevall
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

10.  Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; L Liljeqvist; A S Malmborg; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more
  24 in total

1.  Impact of the Timing of Antibiotic Administration on Digestive Colonization with Carbapenemase-Producing Enterobacteriaceae in a Murine Model.

Authors:  Rémi Le Guern; Teddy Grandjean; Marvin Bauduin; Martin Figeac; Guillaume Millot; Aurore Loquet; Karine Faure; Eric Kipnis; Rodrigue Dessein
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  The Growing Threat of Antibiotic Resistance in Children.

Authors:  Rachel L Medernach; Latania K Logan
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

3.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

4.  Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota.

Authors:  Carola Venturini; Bethany Bowring; Alicia Fajardo-Lubian; Carol Devine; Jonathan Iredell
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Julia A Messina; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Nikole M Scalera; Yohei Doi; Keith S Kaye; Scott Evans; Robert A Bonomo; Vance G Fowler; David van Duin
Journal:  Infect Control Hosp Epidemiol       Date:  2015-12-21       Impact factor: 3.254

6.  Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.

Authors:  Dror Marchaim; Teena Chopra; Ashish Bhargava; Christopher Bogan; Sorabh Dhar; Kayoko Hayakawa; Jason M Pogue; Suchitha Bheemreddy; Christopher Blunden; Maryann Shango; Jessie Swan; Paul R Lephart; Federico Perez; Robert A Bonomo; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2012-06-11       Impact factor: 3.254

7.  Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.

Authors:  Frederik Boetius Hertz; Anders Løbner-Olesen; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units.

Authors:  Evelien A N Oostdijk; Loek Smits; Anne Marie G A de Smet; Maurine A Leverstein-van Hall; Jozef Kesecioglu; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2012-12-01       Impact factor: 17.440

9.  Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis.

Authors:  Linda Chia-Hui Yu; Yi-An Shih; Li-Ling Wu; Yang-Ding Lin; Wei-Ting Kuo; Wei-Hao Peng; Kuo-Shyan Lu; Shu-Chen Wei; Jerrold R Turner; Yen-Hsuan Ni
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

10.  The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.

Authors:  Srinivasa Nithin Gopalsamy; Michael H Woodworth; Tiffany Wang; Cynthia T Carpentieri; Nirja Mehta; Rachel J Friedman-Moraco; Aneesh K Mehta; Christian P Larsen; Colleen S Kraft
Journal:  Am J Med Sci       Date:  2018-08-29       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.